Chembio Diagnostics, FIND to develop HCV POC diagnostic test

World |  News | 0 Comment | 30 Jul, 2018

Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic testing, has announced a collaboration with the Fo...Read more

Siemens Healthineers launches heart attack diagnostic tests

World |  News | 0 Comment | 27 Jul, 2018

Siemens Healthineers has introduced two new assays for quick diagnosis of acute myocardial infarction or heart attack, f...Read more

Merck’s formulation steps further for approval in 21 EU countries

World |  News | 0 Comment | 26 Jul, 2018

Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...Read more

XLerateHealth Accelerator selects ten companies for incoming sixth cohort

World |  News | 0 Comment | 26 Jul, 2018

XLerateHealth, an enterprise-focused healthcare accelerator that helps early-stage healthcare companies has announced it...Read more

GSK signs $300M genetic testing deal

World |  News | 0 Comment | 26 Jul, 2018

Singapore- GlaxoSmithKline has made a $300 million equity investment in the Silicon Valley gene testing compan...Read more

NanoSphere receives patent for nanoparticle delivery of Cannabis

World |  News | 0 Comment | 25 Jul, 2018

NanoSphere Health Sciences has been awarded a breakthrough patent, granting the biotech innovator full ownership over th...Read more

AstraZeneca sells European rights for heart failure treatment for $210M

World |  News | 0 Comment | 24 Jul, 2018

Singapore -  AstraZeneca has agreed to sell the European commercial rights to hypertension and heart...Read more

Biocept, UC collaborate on predicting disease recurrence in solid tumors

World |  News | 0 Comment | 24 Jul, 2018

Singapore -  Biocept, a leading commercial provider of liquid biopsy tests designed to provide physicians with clin...Read more

Tabula Rasa HealthCare’s SinfoníaRx releases RxCompanion 10.0 Software

World |  News | 0 Comment | 24 Jul, 2018

Tabula Rasa HealthCare, Inc., a healthcare technology company optimizing medication safety has announced a new generatio...Read more

FDA approves Tibsovo for AML patients

World |  News | 0 Comment | 23 Jul, 2018

Singapore – The U.S. Food and Drug Administration approved Tibsovo (ivosidenib) tablets for the treatment of adult...Read more

Agios receives nod for ivosidenib

World |  News | 0 Comment | 23 Jul, 2018

Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...Read more

Bayer to stop Essure sales at year-end

World |  News | 0 Comment | 23 Jul, 2018

Singapore –Bayer AG will no longer sell its controversial female contraceptive implant Essure after December 31. T...Read more

FDA approves Pfizer's biosimilar

World |  News | 0 Comment | 23 Jul, 2018

Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected t...Read more

Allergan strikes out with sovereign nation scheme to protect patents

World |  News | 0 Comment | 23 Jul, 2018

Singapore – The U.S. Court of Appeals has affirmed the decision of the USPTO's Patent Trial and Appeal B...Read more

Azafaros to develop new treatments for rare metabolic disorders

World |  News | 0 Comment | 23 Jul, 2018

Azafaros, a spin-off from Leiden University and Amsterdam UMC, focusing on the development of new therapies in the field...Read more

UK Government hosts roundtables with stakeholders from key life science businesses

World |  News | 0 Comment | 23 Jul, 2018

The UK Government, last week, hosted the second in a series of roundtables with stakeholders from key life science busin...Read more

Kite announces collaboration with Gadeta

World |  News | 0 Comment | 23 Jul, 2018

Kite, a Gilead Company and Gadeta B.V., a privately-held company focused on the discovery and development of novel cance...Read more

J&J sells global rights of SYLVANT to EUSA Pharma

World |  News | 0 Comment | 21 Jul, 2018

EUSA Pharma (EUSA), a biopharmaceutical company focused on oncology and rare disease, has entered into a definitive agre...Read more